231 related articles for article (PubMed ID: 7015442)
1. [Heparin in therapeutics (author's transl)].
Capel P
Rev Med Brux; 1981 Mar; 2(3):181-9. PubMed ID: 7015442
[No Abstract] [Full Text] [Related]
2. [Biochemistry of heparin (author's transl)].
Yosizawa Z; Ototani N; Kosakai M
Rinsho Ketsueki; 1981 Jul; 22(7):994-1000. PubMed ID: 7035720
[No Abstract] [Full Text] [Related]
3. Chemistry of heparin and low molecular weight heparin.
Nielsen JI; Ostergaard P
Acta Chir Scand Suppl; 1988; 543():52-6. PubMed ID: 2847458
[No Abstract] [Full Text] [Related]
4. [Mechanism of action of heparin].
Collen D; Hoylaerts M; Lijnen HR
Verh K Acad Geneeskd Belg; 1986; 48(1):33-49. PubMed ID: 3739420
[No Abstract] [Full Text] [Related]
5. The use of an automated analyzer in the evaluation of antithrombin III and heparin.
Scully MF
Semin Thromb Hemost; 1983 Oct; 9(4):309-20. PubMed ID: 6658462
[No Abstract] [Full Text] [Related]
6. Development of heparin fractions: some overlooked considerations.
Fareed J
Semin Thromb Hemost; 1985 Apr; 11(2):227-36. PubMed ID: 3898374
[No Abstract] [Full Text] [Related]
7. [Mechanism of inhibition of blood coagulation (author's transl)].
Kurachi K
Tanpakushitsu Kakusan Koso; 1980 Dec; 25(13):1031-40. PubMed ID: 7025099
[No Abstract] [Full Text] [Related]
8. [Heparin].
Roszkowska W; Worowski K
Postepy Hig Med Dosw; 1984; 38(1):73-124. PubMed ID: 6387687
[No Abstract] [Full Text] [Related]
9. Recent advances in heparin structure, function and clinical usage.
Fussi F
Boll Chim Farm; 1978 Oct; 117(10):561-74. PubMed ID: 743352
[No Abstract] [Full Text] [Related]
10. Heparin: do we understand its antithrombotic actions?
Cines DB
Chest; 1986 Mar; 89(3):420-6. PubMed ID: 3512191
[No Abstract] [Full Text] [Related]
11. [Heparin and antithrombin III (author's transl)].
Kambayashi J; Chang SW; Ohno H; Kobayashi T; Kosaki G
Rinsho Ketsueki; 1981 Jul; 22(7):1010-5. PubMed ID: 7328760
[No Abstract] [Full Text] [Related]
12. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
Kase F; Pospísil J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
[TBL] [Abstract][Full Text] [Related]
13. [Present state of heparin therapy].
Blatrix C; Soulier JP; Vacheron A; Cornu P
Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027
[No Abstract] [Full Text] [Related]
14. Pharmocokinetics of heparin. Distribution and elimination.
Estes JW; Poulin PF
Thromb Diath Haemorrh; 1975 Feb; 33(1):26-37. PubMed ID: 47194
[No Abstract] [Full Text] [Related]
15. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
Ray PK; Harper TA
J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
[No Abstract] [Full Text] [Related]
16. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation].
Sessner HH; Brockhaus W; Kunzmann G; Stingl J
Med Welt; 1971 Jan; 5():187-91. PubMed ID: 5546024
[No Abstract] [Full Text] [Related]
17. Heparin therapy.
Raich PC; Hahn MF; Korst DR
Am Fam Physician; 1974 Sep; 10(3):163-8. PubMed ID: 4413661
[No Abstract] [Full Text] [Related]
18. [Anticoagulant treatment with heparin].
Langer B; Wolosker M; Albers MT
Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741
[No Abstract] [Full Text] [Related]
19. Heparin, antithrombin, and abnormal clotting.
Rosenberg RD
Annu Rev Med; 1978; 29():367-78. PubMed ID: 77142
[No Abstract] [Full Text] [Related]
20. Heparin and the atherosclerotic process.
Engelberg H
Pharmacol Rev; 1984 Jun; 36(2):91-110. PubMed ID: 6379681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
